Date | Time | Source | Announcement |
---|---|---|---|
10 Sep 2009 | 07:00 AM | Re Agreement | |
09 Sep 2009 | 05:00 PM | Holding(s) in Company | |
12 Aug 2009 | 07:00 AM | Director/PDMR Shareholding | |
11 Aug 2009 | 07:00 AM | Publication of papers in peer | |
10 Aug 2009 | 09:28 AM | Publication of pre-clinical d | |
31 Jul 2009 | 11:21 AM | 2008/09 Annual Report and Acc | |
30 Jul 2009 | 10:05 AM | Regulatory Update | |
14 Jul 2009 | 03:48 PM | Launch of "Life Sciences Blue | |
08 Jul 2009 | 09:33 AM | Publication of data on lead C | |
30 Jun 2009 | 07:00 AM | Final Results | |
29 Jun 2009 | 03:44 PM | Holding(s) in Company | |
24 Jun 2009 | 10:30 AM | Holding(s) in Company | |
19 Jun 2009 | 12:17 PM | Notice of Results | |
12 Jun 2009 | 02:56 PM | Holding(s) in Company | |
09 Jun 2009 | 07:00 AM | Stem cells manufacturing cont | |
21 May 2009 | 08:43 AM | Holding(s) in Company | |
19 May 2009 | 01:21 PM | Holding(s) in Company | |
19 May 2009 | 01:18 PM | Holding(s) in Company | |
18 May 2009 | 01:06 PM | Holding(s) in Company | |
18 May 2009 | 07:00 AM | Final Closing of the Placing | |
14 May 2009 | 03:02 PM | Third Closing Of The Placing | |
14 May 2009 | 10:43 AM | Regulatory update | |
01 May 2009 | 07:00 AM | ReN001 data to be presented a | |
09 Apr 2009 | 07:00 AM | Successful automation of stem | |
08 Apr 2009 | 09:51 AM | Holding(s) in Company | |
08 Apr 2009 | 09:43 AM | Holding(s) in Company | |
07 Apr 2009 | 07:00 AM | Second Closing of the Placing | |
06 Apr 2009 | 07:00 AM | Positive pre-clinical data wi | |
03 Apr 2009 | 11:19 AM | Result of EGM and First Closi | |
12 Mar 2009 | 07:00 AM | Announces Fundraising and Con | |
24 Feb 2009 | 04:03 PM | Holding(s) in Company | |
26 Jan 2009 | 07:00 AM | ReNeuron licenses stem cell l | |
21 Jan 2009 | 07:00 AM | ReNeuron clarifies press comm | |
19 Jan 2009 | 07:00 AM | ReNeuron gains approval to co | |
28 Nov 2008 | 07:00 AM | Interim Results | |
24 Nov 2008 | 07:00 AM | Appointment of NED | |
14 Nov 2008 | 03:30 PM | Research Update | |
19 Sep 2008 | 10:46 AM | Result of AGM | |
19 Sep 2008 | 07:00 AM | AGM Statement | |
07 Aug 2008 | 03:33 PM | Annual Report and Accounts | |
15 Jul 2008 | 07:00 AM | Research Update | |
24 Jun 2008 | 07:00 AM | Final Results | |
24 Jun 2008 | 07:00 AM | Re: Fund Raising | |
23 Jun 2008 | 03:38 PM | Holding(s) in Company | |
19 Jun 2008 | 04:33 PM | Notice of Results | |
11 Jun 2008 | 07:00 AM | Re: ISSCR Conference | |
29 May 2008 | 07:00 AM | Re: Contract | |
21 May 2008 | 07:00 AM | Notice of US Patent Grant | |
20 May 2008 | 10:46 AM | Re: UK Government Vote | |
23 Apr 2008 | 07:00 AM | Research Update |
ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.
It listed on AIM in 2006 under the ticker RENE.